134 related articles for article (PubMed ID: 20382049)
1. Topography of the masseter muscle in relation to treatment with botulinum toxin type A.
Hu KS; Kim ST; Hur MS; Park JH; Song WC; Koh KS; Kim HJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):167-71. PubMed ID: 20382049
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular nerve distribution of the masseter muscle as a basis for botulinum toxin injection.
Kim DH; Hong HS; Won SY; Kim HJ; Hu KS; Choi JH; Kim HJ
J Craniofac Surg; 2010 Mar; 21(2):588-91. PubMed ID: 20489458
[TBL] [Abstract][Full Text] [Related]
3. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
Kwon JS; Kim ST; Jeon YM; Choi JH
Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136
[TBL] [Abstract][Full Text] [Related]
4. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.
Kaya B; Apaydin N; Loukas M; Tubbs RS
J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1663-8. PubMed ID: 25175271
[TBL] [Abstract][Full Text] [Related]
5. Botox facial slimming/facial sculpting: the role of botulinum toxin-A in the treatment of hypertrophic masseteric muscle and parotid enlargement to narrow the lower facial width.
Wu WT
Facial Plast Surg Clin North Am; 2010 Feb; 18(1):133-40. PubMed ID: 20206096
[TBL] [Abstract][Full Text] [Related]
6. Comparison between intramuscular and perimuscular injections of botulinum toxin type A.
Campos JH; Oliveira LB; Queiroz TO; Santos KP; Freitas FM
Aesthetic Plast Surg; 2006; 30(6):700-3; discussion 704. PubMed ID: 16977369
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
de Ru JA; Buwalda J
J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
[TBL] [Abstract][Full Text] [Related]
8. Lower facial contouring with botulinum toxin type A.
Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
[TBL] [Abstract][Full Text] [Related]
9. The medical management of masseteric hypertrophy with botulinum toxin.
Finn S; Ryan P; Sleeman D
J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
11. The use of botulinum toxin for the treatment of temporomandibular disorder.
Freund B; Schwartz M
Oral Health; 1998 Feb; 88(2):32-7. PubMed ID: 9610334
[No Abstract] [Full Text] [Related]
12. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
[TBL] [Abstract][Full Text] [Related]
13. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder.
Haferkamp A; Schurch B; Reitz A; Krengel U; Grosse J; Kramer G; Schumacher S; Bastian PJ; Büttner R; Müller SC; Stöhrer M
Eur Urol; 2004 Dec; 46(6):784-91. PubMed ID: 15548448
[TBL] [Abstract][Full Text] [Related]
14. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle.
Tsai CY; Chiu WC; Liao YH; Tsai CM
Am J Orthod Dentofacial Orthop; 2009 Feb; 135(2):142.e1-6; discussion 142-3. PubMed ID: 19201315
[TBL] [Abstract][Full Text] [Related]
15. The treatment of masseter hypertrophy with botulinum toxin type A.
Al-Ahmad HT; Al-Qudah MA
Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107
[TBL] [Abstract][Full Text] [Related]
16. The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy.
Bae JH; Choi DY; Lee JG; Seo KK; Tansatit T; Kim HJ
Dermatol Surg; 2014 Dec; 40(12):1334-9. PubMed ID: 25393348
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin. The Newport Beach experience.
Fulton JE
Dermatol Surg; 1998 Nov; 24(11):1219-24. PubMed ID: 9834742
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
Casserly P; Timon C
J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
[TBL] [Abstract][Full Text] [Related]
19. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
Farahvash MR; Arad S
J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
[TBL] [Abstract][Full Text] [Related]
20. Midface lifting with botulinum toxin: intradermal technique.
Petchngaovilai C
J Cosmet Dermatol; 2009 Dec; 8(4):312-6. PubMed ID: 19958437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
